Patents by Inventor Larry Green

Larry Green has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modular planter box
    Patent number: 12219909
    Abstract: A modular planter box defining a storage cavity therein that is configured to receive a planting medium, the modular planter box including a first side-wall extending longitudinally in a first direction and having a bottom end configured to rest on a supporting surface, a second side-wall extending longitudinally in a second direction, and a bottom wall residing on an imaginary plane. The second side-wall extends in a third direction that is normal to the imaginary horizontal plane. The bottom wall is spaced from a bottom end of the first side-wall in the third direction and towards an opposite, top end of the first side-wall. The second side-wall is positioned closer to a first end of the first side-wall than a second end thereof, and the second side-wall is spaced from the first end of the first side-wall in the first direction and towards the second end of the first side-wall.
    Type: Grant
    Filed: November 14, 2022
    Date of Patent: February 11, 2025
    Inventors: Larry Greenes, Dwaine Mellon
  • ANTI-CD47 ANTIBODIES
    Publication number: 20220267440
    Abstract: The present invention provides anti-CD47 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic and diagnostic methods for the treatment of cancer, ischemic-reperfusion injury, and other diseases.
    Type: Application
    Filed: May 6, 2022
    Publication date: August 25, 2022
    Inventors: John Lippincott, Dana Duey, Larry Green
  • Anti-CD47 antibodies
    Patent number: 11352425
    Abstract: The present invention provides anti-CD47 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic and diagnostic methods for the treatment of cancer, ischemic-reperfusion injury, and other diseases.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: June 7, 2022
    Assignee: ABSOS, LLC
    Inventors: John Lippincott, Dana Duey, Larry Green
  • Genetic engineering of non-human animals for the production of chimeric antibodies
    Patent number: 11352444
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: June 7, 2022
    Assignee: ABLEXIS, LLC
    Inventors: Larry Green, Hiroaki Shizuya
  • Genetic engineering of non-human animals for the production of chimeric antibodies
    Patent number: 11242409
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: February 8, 2022
    Assignee: ABLEXIS, LLC
    Inventors: Larry Green, Hiroaki Shizuya
  • Genetic engineering of non-human animals for the production of chimeric antibodies
    Patent number: 11220555
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Grant
    Filed: August 19, 2020
    Date of Patent: January 11, 2022
    Assignee: ABLEXIS, LLC
    Inventors: Larry Green, Hiroaki Shizuya
  • Genetic engineering of non-human animals for the production of chimeric antibodies
    Patent number: 11104744
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: August 31, 2021
    Assignee: ABLEXIS, LLC
    Inventors: Larry Green, Hiroaki Shizuya
  • Genetic engineering of non-human animals for the production of chimeric antibodies
    Patent number: 11104743
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: August 31, 2021
    Assignee: ABLEXIS, LLC
    Inventors: Larry Green, Hiroaki Shizuya
  • GENETIC ENGINEERING OF NON-HUMAN ANIMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES
    Publication number: 20210002385
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Application
    Filed: September 15, 2020
    Publication date: January 7, 2021
    Inventors: Larry Green, Hiroaki Shizuya
  • GENETIC ENGINEERING OF NON-HUMAN ANIMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES
    Publication number: 20200407466
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Application
    Filed: September 15, 2020
    Publication date: December 31, 2020
    Inventors: Larry Green, Hiroaki Shizuya
  • GENETIC ENGINEERING OF NON-HUMAN ANIMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES
    Publication number: 20200407464
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Application
    Filed: September 15, 2020
    Publication date: December 31, 2020
    Inventors: Larry Green, Hiroaki Shizuya
  • GENETIC ENGINEERING OF NON-HUMAN ANIMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES
    Publication number: 20200407465
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Application
    Filed: September 15, 2020
    Publication date: December 31, 2020
    Inventors: Larry Green, Hiroaki Shizuya
  • GENETIC ENGINEERING OF NON-HUMAN ANIMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES
    Publication number: 20200377619
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Application
    Filed: August 19, 2020
    Publication date: December 3, 2020
    Inventors: Larry Green, Hiroaki Shizuya
  • Genetic engineering of non-human animals for the production of chimeric antibodies
    Patent number: 10836832
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: November 17, 2020
    Assignee: ABLEXIS, LLC
    Inventors: Larry Green, Hiroaki Shizuya
  • Genetic engineering of non-human animals for the production of chimeric antibodies
    Patent number: 10829564
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: November 10, 2020
    Assignee: ABLEXIS, LLC
    Inventors: Larry Green, Hiroaki Shizuya
  • Key fob for a key management system
    Patent number: 10748363
    Abstract: A key fob for retaining a key or other object, including: a body structure manufactured from a printed circuit board material; a key ring structure manufactured from the printed circuit board material coupled to the body structure; and a conductive loop disposed one or more of within, on a surface of, and coupled to the printed circuit board material of the key ring structure. Optionally, the body structure and the key ring structure are integrally formed from the printed circuit board material.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: August 18, 2020
    Assignee: Marcon International Inc
    Inventors: Bobby Jain, Ric Stone, Larry Green
  • GENETIC ENGINEERING OF NON-HUMAN ANIMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES
    Publication number: 20200181286
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Application
    Filed: February 13, 2020
    Publication date: June 11, 2020
    Inventors: Larry Green, Hiroaki Shizuya
  • GENETIC ENGINEERING OF NON-HUMAN ANIMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES
    Publication number: 20200181285
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Application
    Filed: February 13, 2020
    Publication date: June 11, 2020
    Inventors: Larry Green, Hiroaki Shizuya
  • Genetic engineering of non-human animals for the production of chimeric antibodies
    Patent number: 10662255
    Abstract: The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: May 26, 2020
    Assignee: Ablexis, LLC
    Inventors: Larry Green, Hiroaki Shizuya
  • Non-human mammals for the production of chimeric antibodies
    Patent number: 10638736
    Abstract: The invention provides knock-in non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing knock-in cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention.
    Type: Grant
    Filed: April 11, 2016
    Date of Patent: May 5, 2020
    Assignee: ABLEXIS, LLC
    Inventors: Larry Green, Hiroaki Shizuya